Monomer component with selective butyrylcholinesterase inhibitory effect in bletilla and its use
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound, drug technology, applied in the field of medicine
Active Publication Date: 2020-10-23
SICHUAN UNIV
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Recently, we have extracted and separated several phenanthrene and dihydrophenanthrene compounds with strong selective butyrylcholinesterase inhibitory effect from Radix Bletifera. see the report
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0031] Embodiment 1: the method for the extraction, separation, purification of all compounds of the present invention:
[0032] 1.1 Plant source and identification:
[0033] In July 2015, it was purchased at the Hehuachi Medicinal Materials Market in Chengdu. It was identified as Baiji by Mr. Liu Wenbin, School of Chemical Engineering, Sichuan University. Bletilla striata(Thunb) The tuber of Reichb. f.
[0034] 1.2 Extraction and separation of Baiji medicinal materials and structural identification of compounds
[0035] (1) Take 2 kg of Baiji medicinal material, crush it into a coarse powder, and heat extract it with 95% ethanol at 50 °C. The amount of ethanol is 5 times the weight of the medicinal material. The extraction time is 24 h each time, and the extraction times are 5 times.
[0036] (2) Filter the extract and combine the filtrates. Concentrate under reduced pressure below 45 ℃ to form an extract.
[0037] (3) Use a small amount of distilled water to suspend the ...
Embodiment 2
[0070] Embodiment 2: In vitro inhibitory activity detection of compound 1-12 to cholinesterase
[0071] 12 phenanthrene and dihydrophenanthrene compounds used for activity detection are shown in Table I:
[0072] Table 1 Compounds isolated from EtOAc parts of Bletilla striat
[0073]
[0074]
[0075] According to the literature and optimized screening model for acetyl and butyrylcholinesterase inhibitors, the cholinesterase inhibitory activity of compounds 1-12 was tested, and all 12 compounds showed strong butyrylcholinesterase inhibitory activity . Its activity data are shown in Table II:
[0076] Table 2 The cholinesterase inhibitory activity of 12 compounds isolated from Bletilla striata in vitro.
[0077]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the field of medicine science and technology, and particularly relates to monomer compounds having selective butyrylcholinesterase inhibitory activity obtained by performing separation from orchidaceae Bletilla striata (Thunb)Reichb.f. and medicial salt thereof, and a pharmaceutical composition containing the compounds. The 12 compounds disclosed by the invention have selective inhibitory effects on butyrylcholinesterase to different extents, and IC50 values of five of the 12 compounds are smaller than 10 micrometers, so that a powerful butyrylcholinesterase inhibitoryeffect is shown, and a unique advantage of the compounds in treatment of senile dementia diseases.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to the extraction and separation of natural product active ingredients and its application. The present invention relates to a variety of phenanthrene and dihydrophenanthrene compounds with strong selective butyrylcholinesterase inhibitory activity and their pharmaceutically acceptable salts, as well as pharmaceuticals containing these compounds, which are isolated from Orchidaceae Radix. pharmaceutical composition. They can be expected to be used in the prevention and treatment of learning and memory impairment and senile dementia. Background technique [0002] Alzheimer's disease (AD) occurs in old age and pre-senile age, and is a progressive neurodegenerative disease characterized by behavioral impairment and progressive cognitive impairment. Since there is no effective method to cure and control the progress of the disease, AD has become an important disease that threatens th...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.